144 related articles for article (PubMed ID: 37705026)
21. Prognostic Factors and Survival According to Tumor Subtype in Women With Breast Cancer Brain Metastases.
Lopes S; Vieira I; Abreu M; Pousa I; Ferreira A; Sousa S; Pereira D
Curr Probl Cancer; 2022 Dec; 46(6):100866. PubMed ID: 36179388
[TBL] [Abstract][Full Text] [Related]
22. A Predictive Model for the Early Death of Breast Cancer With Synchronous Liver Metastases: A Population-Based Study.
Liu S; Jia Y; Chai J; Ge H; Huang R; Li A; Cheng H
Cancer Control; 2023; 30():10732748231202851. PubMed ID: 37724916
[TBL] [Abstract][Full Text] [Related]
23. Different risk and prognostic factors for liver metastasis of breast cancer patients with
Zhang N; Xiang Y; Shao Q; Wu J; Liu Y; Long H; Tao D; Zeng X
Front Oncol; 2023; 13():1102853. PubMed ID: 37124528
[TBL] [Abstract][Full Text] [Related]
24. Prognostic factors and survival according to tumour subtype in women presenting with breast cancer bone metastases at initial diagnosis: a SEER-based study.
Li X; Zhang X; Liu J; Shen Y
BMC Cancer; 2020 Nov; 20(1):1102. PubMed ID: 33187507
[TBL] [Abstract][Full Text] [Related]
25. Repeat Hepatectomy for Breast Cancer Liver Metastases.
Ruiz A; Castro-Benitez C; Sebagh M; Giacchetti S; Castro-Santa E; Wicherts DA; van Hillegersberg R; Paule B; Castaing D; Morère JF; Adam R
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1057-66. PubMed ID: 26259753
[TBL] [Abstract][Full Text] [Related]
26. HER2 Receptor Conversion Is a strong Survival Predictor in Patients with Breast Cancer Brain Metastases.
Michel A; Oppong MD; Rauschenbach L; Pierscianek D; Dinger TF; Schmidt T; Hense J; Pöttgen C; Kimmig R; Ahmadipour Y; Özkan N; Müller O; Junker A; Sure U; Jabbarli R; El Hindy N
World Neurosurg; 2021 Aug; 152():e332-e343. PubMed ID: 34062302
[TBL] [Abstract][Full Text] [Related]
27. Differential response of immunohistochemically defined breast cancer subtypes to anthracycline-based adjuvant chemotherapy with or without paclitaxel.
Fountzilas G; Dafni U; Bobos M; Batistatou A; Kotoula V; Trihia H; Malamou-Mitsi V; Miliaras S; Chrisafi S; Papadopoulos S; Sotiropoulou M; Filippidis T; Gogas H; Koletsa T; Bafaloukos D; Televantou D; Kalogeras KT; Pectasides D; Skarlos DV; Koutras A; Dimopoulos MA
PLoS One; 2012; 7(6):e37946. PubMed ID: 22679488
[TBL] [Abstract][Full Text] [Related]
28. Comparative study of receptor discordance between primary and corresponding metastatic lesions in breast cancer.
Erdem GU; Altundag K; Ozdemir NY; Sahin S; Demirci NS; Karatas F; Bozkaya Y; Aytekin A; Tasdemir V; Aslan AC; Sever AR; Zengin N
J BUON; 2017; 22(2):365-376. PubMed ID: 28534357
[TBL] [Abstract][Full Text] [Related]
29. The prognostic contribution of clinical breast cancer subtype, age, and race among patients with breast cancer brain metastases.
Anders CK; Deal AM; Miller CR; Khorram C; Meng H; Burrows E; Livasy C; Fritchie K; Ewend MG; Perou CM; Carey LA
Cancer; 2011 Apr; 117(8):1602-11. PubMed ID: 21472708
[TBL] [Abstract][Full Text] [Related]
30. Real-world data on breast pathologic complete response and disease-free survival after neoadjuvant chemotherapy for hormone receptor-positive, human epidermal growth factor receptor-2-negative breast cancer: a multicenter, retrospective study in China.
Guan D; Jie Q; Wu Y; Xu Y; Hong W; Meng X
World J Surg Oncol; 2022 Sep; 20(1):326. PubMed ID: 36175898
[TBL] [Abstract][Full Text] [Related]
31. Profile and Outcome of Supraclavicular Metastases in Patients with Metastatic Breast Cancer: Discordance of Receptor Status Between Primary and Metastatic Site.
Thangarajah F; Vogel C; Pahmeyer C; Eichler C; Holtschmidt J; Ratiu D; Mallmann P; Malter W
Anticancer Res; 2018 Oct; 38(10):6023-6026. PubMed ID: 30275235
[TBL] [Abstract][Full Text] [Related]
32. Discordance and Conversion Rates of Progesterone-, Estrogen-, and HER2/neu-Receptor Status in Primary Breast Cancer and Brain Metastasis Mainly Triggered by Hormone Therapy.
Timmer M; Werner JM; Röhn G; Ortmann M; Blau T; Cramer C; Stavrinou P; Krischek B; Mallman P; Goldbrunner R
Anticancer Res; 2017 Sep; 37(9):4859-4865. PubMed ID: 28870906
[TBL] [Abstract][Full Text] [Related]
33. Resection of liver metastases from breast cancer: a multicentre analysis.
He X; Zhang Q; Feng Y; Li Z; Pan Q; Zhao Y; Zhu W; Zhang N; Zhou J; Wang L; Wang M; Liu Z; Zhu H; Shao Z; Wang L
Clin Transl Oncol; 2020 Apr; 22(4):512-521. PubMed ID: 31230220
[TBL] [Abstract][Full Text] [Related]
34. Prognostic Value of Brain Metastasis-Free Interval in Patients with Breast Cancer Brain Metastases.
Hulsbergen AFC; Lamba N; Claes A; Kavouridis VK; Lin NU; Smith TR; Verhoeff JJC; Broekman MLD
World Neurosurg; 2019 Aug; 128():e157-e164. PubMed ID: 31035019
[TBL] [Abstract][Full Text] [Related]
35. Long-term outcomes and prognostic analysis of percutaneous radiofrequency ablation in liver metastasis from breast cancer.
Bai XM; Yang W; Zhang ZY; Jiang AN; Wu W; Lee JC; Chen MH; Yan K
Int J Hyperthermia; 2019 Jan; 35(1):183-193. PubMed ID: 30200791
[TBL] [Abstract][Full Text] [Related]
36. Biomarker expression and St Gallen molecular subtype classification in primary tumours, synchronous lymph node metastases and asynchronous relapses in primary breast cancer patients with 10 years' follow-up.
Falck AK; Bendahl PO; Chebil G; Olsson H; Fernö M; Rydén L
Breast Cancer Res Treat; 2013 Jul; 140(1):93-104. PubMed ID: 23807420
[TBL] [Abstract][Full Text] [Related]
37. Extended time interval between diagnosis and surgery does not improve the outcome in patients operated for resection or ablation of breast cancer liver metastases.
Lucidi V; Bohlok A; Liberale G; Bez M; Germanova D; Bouazza F; Demetter P; Larsimont D; Aftimos P; Smoll NR; Donckier V
Eur J Surg Oncol; 2020 Feb; 46(2):229-234. PubMed ID: 31677938
[TBL] [Abstract][Full Text] [Related]
38. Impact of triple negative phenotype on breast cancer prognosis.
Kaplan HG; Malmgren JA
Breast J; 2008; 14(5):456-63. PubMed ID: 18657139
[TBL] [Abstract][Full Text] [Related]
39. [Hepatic resection for breast cancer metastases: results and prognosis (65 cases)].
Pocard M; Pouillart P; Asselain B; Falcou MC; Salmon RJ
Ann Chir; 2001 Jun; 126(5):413-20. PubMed ID: 11447791
[TBL] [Abstract][Full Text] [Related]
40. A meta-analysis of oestrogen receptor, progesterone receptor and human epidermal growth factor receptor 2 discordance between primary breast cancer and metastases.
Aurilio G; Disalvatore D; Pruneri G; Bagnardi V; Viale G; Curigliano G; Adamoli L; Munzone E; Sciandivasci A; De Vita F; Goldhirsch A; Nolè F
Eur J Cancer; 2014 Jan; 50(2):277-89. PubMed ID: 24269135
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
